The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the…
Continue Reading
News Source: medicalxpress.com
FDA approves label expansion for Vyvgart, Vyvgart Hytrulo for generalized myasthenia gravis
Leave a Reply